Hiroaki Shigeta
Keine laufenden Positionen mehr
Profil
Hiroaki Shigeta served as Chairman at Nippon Roche KK from 2001 to 2002.
He was also the Head-Far East Relations at Hoffmann-La Roche, Inc. from 2003 to 2004.
Shigeta was a Director at Chugai Pharmaceutical Co., Ltd.
in 2002 to 2003.
He served as an Independent Director at MediciNova, Inc. from 2011 to 2015.
Additionally, he was the Lead Independent Director at The Medicines Co. in 2012 to 2013.
Shigeta earned his undergraduate degree from Momoyama Gakuin University and another undergraduate degree from Haas School of Business.
Ehemalige bekannte Positionen von Hiroaki Shigeta
| Unternehmen | Position | Ende |
|---|---|---|
| MEDICINOVA, INC. | Direktor/Vorstandsmitglied | 11.06.2015 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Direktor/Vorstandsmitglied | 01.12.2004 |
| CHUGAI PHARMACEUTICAL CO., LTD | Direktor/Vorstandsmitglied | 01.04.2003 |
Nippon Roche KK
 Nippon Roche KK Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Nippon Roche KK is a Japanese company that manufactures and sells pharmaceuticals. The company is based in Tokyo, Japan. Nippon Roche KK was acquired by Chugai Pharmaceutical Co., Ltd. from Roche Holding AG on October 01, 2002 for $1,613.74 million. | Vorstandsvorsitzender | 01.12.2000 |
| THE MEDICINES COMPANY | Direktor/Vorstandsmitglied | - |
Ausbildung von Hiroaki Shigeta
| Momoyama Gakuin University | Undergraduate Degree |
| Haas School of Business | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MEDICINOVA, INC. | Health Technology |
| CHUGAI PHARMACEUTICAL CO., LTD | Health Technology |
| Private Unternehmen | 3 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Nippon Roche KK
Nippon Roche KK Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Nippon Roche KK is a Japanese company that manufactures and sells pharmaceuticals. The company is based in Tokyo, Japan. Nippon Roche KK was acquired by Chugai Pharmaceutical Co., Ltd. from Roche Holding AG on October 01, 2002 for $1,613.74 million. | Health Technology |
